BioStem Technologies, Inc.
BSEM
$4.38
-$0.46-9.60%
OTC PK
| 06/30/2025 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -32.03% | 77.77% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -32.03% | 77.77% | |||
| Cost of Revenue | -19.71% | 68.47% | |||
| Gross Profit | -32.18% | 78.29% | |||
| SG&A Expenses | -28.14% | 76.81% | |||
| Depreciation & Amortization | 12.41% | 0.74% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -26.90% | 76.08% | |||
| Operating Income | -97.85% | 91.40% | |||
| Income Before Tax | -96.63% | 95.32% | |||
| Income Tax Expenses | -6.91% | 95.32% | |||
| Earnings from Continuing Operations | -112.59% | 95.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -112.59% | 95.32% | |||
| EBIT | -97.85% | 91.40% | |||
| EBITDA | -96.73% | 90.29% | |||
| EPS Basic | -112.57% | 95.59% | |||
| Normalized Basic EPS | -96.61% | 95.48% | |||
| EPS Diluted | -119.88% | 118.18% | |||
| Normalized Diluted EPS | -94.67% | 114.17% | |||
| Average Basic Shares Outstanding | 0.21% | -0.12% | |||
| Average Diluted Shares Outstanding | -36.37% | -8.82% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||